Psoriatic Arthritis Excellence Forum Excellence Forum

Psoriatic Arthritis

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Q&As

Q&A: Screening for PsA in Psoriasis Is Key

01/07/2019

Although estimates of the proportion of psoriasis patients who also have psoriatic arthritis (PsA) have varied widely in the past, new data published in the Journal of the American Academy of Dermatology suggest that approximately 1 in 4...

Although estimates of the...

01/07/2019

Rheumatology & Arthritis

Q&A

Alexis Ogdie, MD, on Tolerance of Methotrexate and TNFis Among Patients with PsA and RA

10/19/2012

Dr Ogdie answered our questions about her recent research into how patients with psoriatic arthritis and rheumatoid arthritis tolerate different therapies.

Dr Ogdie answered our questions...

10/19/2012

Rheumatology & Arthritis

Q&A

Neal Birnbaum, MD, on Progression in Psoriatic Arthritis

05/09/2011

Dr Neal Birnbaum, from California Pacific Medical Center in San Francisco, answers our questions about identifying and managing the progression of disease among patients with psoriatic arthritis.

Dr Neal Birnbaum, from...

05/09/2011

Rheumatology & Arthritis

Q&A

Laura Coates, MBChB, on GRAPPA Guidelines on PsA

06/02/2002

Dr Laura Coates of the University of Oxford (UK) details some key changes in the recommendations of the The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis on treatment of PsA, comorbities and associated conditions.

Dr Laura Coates of the...

06/02/2002

Rheumatology & Arthritis

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Sponsored

Test Your Knowledge

Obesity as a Chronic Inflammatory State Impacting Spondyloarthritis (SpA)

10/01/2024

Understand obesity as a chronic disease and a contributor to underlying inflammatory activity that directly and negatively impacts patients with spondyloarthritis (SpA).

Understand obesity as a chronic...

10/01/2024

Rheumatology & Arthritis

Sponsored

Test Your Knowledge

Impact of Comorbid Obesity on Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA) Patient Outcomes

10/01/2024

Assess your understanding of the impact of obesity on psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) patient outcomes.

Assess your understanding of the...

10/01/2024

Rheumatology & Arthritis

Sponsored

Test Your Knowledge

Importance of Holistic Management of Obesity in Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA) Patient Populations

10/01/2024

Take this quick quiz to deepen your understanding of the role holistic management plays in improving outcomes for psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) patients with obesity.

Take this quick quiz to deepen...

10/01/2024

Rheumatology & Arthritis

Sponsored

Charting the Course Toward Improved Patient Outcomes in Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA)

11/10/2023

In this white paper, leading experts in the treatment of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) summarize the educational gaps among health care providers that are preventing optimal patient care....

In this white paper, leading...

11/10/2023

Dermatology

FDA Alert

FDA Approves Bimekizumab for PsA, nr-axSpA and AS

09/23/2024

Rebecca Mashaw ;

Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).

Already approved for plaque...

09/23/2024

Rheumatology & Arthritis

Psoriatic Arthritis Excellence Forum Excellence Forum

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products